Research Output per year
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2006 2019
Repeatability of [ 18 F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
Kolinger, G. D., Vállez García, D., Kramer, G. M., Frings, V., Smit, E. F., de Langen, A. J., Dierckx, R. A. J. O., Hoekstra, O. S. & Boellaard, R., 2019, In : EJNMMI Research. 9, 14.Research output: Contribution to journal › Article › Academic › peer-review
Treatment of oncogene-driven non-small cell lung cancer
Kastelijn, E. A., de Langen, A. J. & Peters, B. J. M., 2019, In : Current opinion in pulmonary medicine. 25, 3, p. 300-307Research output: Contribution to journal › Article › Academic › peer-review
Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion-Positive Advanced NSCLC
van Veggel, B., de Langen, A. J., Hashemi, S. M. S., Monkhorst, K., Heideman, D. A. M., Thunnissen, E. & Smit, E. F., 1 Aug 2018, In : Journal of Thoracic Oncology. 13, 8, p. 1222-1226 5 p.Research output: Contribution to journal › Article › Academic › peer-review
A population-based study of outcomes in surgically resected T3N0 non-small cell lung cancer in the Netherlands, defined using TNM-7 and TNM-8; justification of changes and an argument to incorporate histology in the staging algorithm?
Blaauwgeers, H., Damhuis, R., Lissenberg-Witte, B., de Langen, A. J., Senan, S. & Thunnissen, E., 5 Nov 2018, In : Journal of Thoracic Oncology.Research output: Contribution to journal › Article › Academic › peer-review
Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses
van Veggel, B., de Langen, A. J., Hashemi, S., Monkhorst, K., Rosenberg, E. H., Heideman, D. A. M., Radonic, T. & Smit, E. F., 2018, In : Lung Cancer. 124, p. 130-134 5 p.Research output: Contribution to journal › Article › Academic › peer-review